P. Marichal et al., MOLECULAR-BIOLOGICAL CHARACTERIZATION OF AN AZOLE-RESISTANT CANDIDA-GLABRATA ISOLATE, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2229-2237
Two isolates of Candida glabrata, one susceptible and one resistant to
azole antifungals, were previously shown to differ in quantity and ac
tivity of the cytochrome P-450 14 alpha-lanosteral demethylase which i
s the target for azole antifungals. The resistant isolate also had a l
ower intracellular level of fluconazole, but not of ketoconazole or it
raconazole, than the susceptible isolate. In the present study a 3.7-f
old increase in the copy number of the CYP51 gene, encoding the 14 alp
ha-lanosterol demethylase, was found. The amount of CYP51 mRNA transcr
ipt in the resistant isolate was eight times greater than it was in th
e susceptible isolate. Hybridization experiments on chromosomal blots
indicated that this increase in copy number was due to duplication of
the entire chromosome containing the CYP51 gene. The phenotypic instab
ility of the resistant isolate was demonstrated genotypically: a gradu
al loss of the duplicated chromosome was seen in successive subculture
s of the isolate in fluconazole-free medium and correlated with revers
ion to susceptibility. The greater abundance of the amplified chromoso
me induced pronounced differences in the protein patterns of the susce
ptible and revertant isolates versus that of the resistant isolate, as
demonstrated by two dimensional gel electrophoresis (2D-GE). Densitom
etry of the 2D-GE product indicated upregulation of at least 25 protei
ns and domnregulation of at least 76 proteins in the resistant isolate
.